Ajax Biosciences SL

Ajax Biosciences SL

AjaxDNA targets the gap in precission between in silico predictions and real applications of biotechnology for the pharma industry. Our product, LabOnAcell solves this through unlimited parallelization of biological experiments and whole cell digital twins powered by mathematical and AI multiomic modeling. We automate screening to solve the inneficiencies specifically in drug discovery, disease mechanistic understanding and preclinical trials. This automated approach reduces development costs by up to 95% and time by over 60% a disruptive value proposition that is already generating revenue through early adopters in industrial biotechnology and is backed by strategic alliances with entities like Valencia Innovation Capital to scale our "LabOnACell" hardware & software.

Health + MedTech, IT Solutions, Manufacturing, Startups, AI & Quantum Computing